IFI30 and glioblastoma: In addition, the IFI30 expression level could distinguish the prognosis of patients with LGG with a mutant IDH (IDH‐mut) and non‐codeleted 1p/19q (1p/19q non‐codel) in the data set from the CGGA (Figure S1A), and patients with GBM with IDH‐wt in the data set from TCGA (Figure S2E).